acut
respiratori
distress
syndrom
ard
caus
sever
sepsi
remain
major
challeng
intens
care
medicin
shown
protect
lung
injuri
howev
mechan
protect
effect
ard
larg
unknown
report
prevent
lpsinduc
ard
inhibit
mapk
signal
pathway
lentivir
packag
cdna
shrna
intratrach
administr
lung
male
sd
rat
two
week
gene
transfer
anim
receiv
lp
mgkg
inject
alon
combin
ma
receptor
antagonist
inhibitor
mgkg
pretreat
lpsinduc
lung
injuri
inflammatori
respons
significantli
prevent
overexpress
deterior
shrna
pretreat
abolish
protect
effect
moreov
overexpress
significantli
reduc
ang
iiang
ratio
balf
upregul
ma
mrna
express
lung
revers
importantli
blockad
lpsinduc
phosphoryl
also
abolish
wherea
inhibitor
significantli
attenu
lung
injuri
overexpress
rat
pretreat
observ
suggest
attenu
lpsinduc
ard
via
ang
ma
pathway
inhibit
activ
acut
respiratori
distress
syndrom
ard
remain
major
caus
mortal
morbid
intens
care
ard
type
acut
diffus
inflammatori
lung
injuri
caus
releas
proinflammatori
cytokin
recruit
granulocyt
monocyt
lung
lead
increas
pulmonari
vascular
permeabl
loss
aerat
alveolu
present
effect
therapi
ard
protect
mechan
ventil
low
tidal
volum
mlkg
specif
effect
pharmacolog
intervent
ard
current
avail
therefor
urgent
identifi
valid
develop
pharmaceut
drug
treatment
ard
angiotensinconvert
enzym
homologu
ace
share
approxim
homolog
sequenc
catalyt
domain
ace
act
endogen
counterregul
ace
contrast
ace
cleav
angiotensin
ang
ang
ii
primarili
hydrolyz
ang
ii
ang
ang
ii
trigger
vasoconstrict
inflamm
prolifer
apoptosi
via
bind
specif
ang
ii
type
receptor
ang
counteract
effect
ang
ii
via
g
proteincoupl
receptor
ma
therefor
balanc
ace
influenc
endogen
ratio
ang
ii
ang
consequ
contribut
regul
tension
vascular
well
inflammatori
respons
organ
function
injuri
accumul
evid
indic
play
import
role
pathophysiolog
ard
identifi
key
receptor
coronaviru
caus
sever
acut
respiratori
syndrom
level
human
airway
epithelia
posit
correl
coronaviru
infect
compar
wild
type
mice
knockout
mice
exhibit
impair
exercis
capac
wors
lung
function
exacerb
lung
fibrosi
model
bleomycininduc
lung
injuri
furthermor
three
anim
model
ard
knockout
mice
show
sever
lung
diseas
includ
enhanc
vascular
permeabl
increas
lung
edema
compar
wild
type
mice
treatment
recombin
effect
improv
symptom
attenu
arteri
hypoxemia
piglet
model
lipopolysaccharid
lp
induc
ard
thu
play
protect
role
ard
potenti
develop
drug
ard
therapi
howev
underli
molecular
mechan
prevent
ard
remain
elus
previou
studi
show
activ
mitogenactiv
protein
kinas
mapk
pathway
associ
process
ard
phosphoryl
level
mapk
extracellular
signalregul
kinas
erk
jun
ntermin
kinas
jnk
significantli
increas
lpsinduc
lung
injuri
consequ
inhibit
mapk
erk
effici
attenu
lpsinduc
pulmonari
inflammatori
respons
activ
mapk
lung
associ
periton
sepsisinduc
pulmonari
edema
leukocyt
infiltr
interestingli
ferreira
et
al
recent
found
activ
cardiac
prevent
hypertensioninduc
cardiac
fibrosi
inhibit
erk
phosphoryl
moreov
blocker
telmisartan
exert
protect
effect
heart
failur
upregul
myocardi
level
inhibit
mapk
erk
jnk
phosphoryl
activ
mapk
pathway
also
involv
regul
mrna
express
rat
vascular
smooth
muscl
cell
addit
lp
stimul
activ
b
signal
pathway
via
bind
tolllik
receptor
close
relat
lpsinduc
lung
injuri
inflamm
previou
vitro
studi
demonstr
prevent
rat
pulmonari
microvascular
endotheli
cell
pmvec
lpsinduc
apoptosi
inflamm
inhibit
activ
jnk
b
pathway
therefor
hypothes
may
protect
lpsinduc
acut
lung
injuri
inhibit
mapk
b
pathway
varieti
anim
speci
use
studi
lpsinduc
lung
injuri
howev
intraspeci
differ
biolog
respons
lp
challeng
lead
inconsist
publish
result
rat
mous
model
wide
use
model
ard
research
recent
research
shown
dispar
lp
structur
recogn
human
mice
may
contribut
variabl
respons
lpsinduc
ard
addit
rel
small
mass
mice
may
prohibit
measur
physiolog
paramet
also
make
difficult
obtain
suffici
quantiti
sampl
blood
plasma
balf
present
studi
appli
lentiviralmedi
gene
deliveri
approach
overexpress
knock
rat
lung
tissu
investig
whether
pulmonari
overexpress
exert
benefici
effect
lpsinduc
lung
injuri
via
suppress
mapk
b
pathway
pvdf
membran
viral
titer
evalu
gradient
dilut
packag
lentivirus
design
recombin
lentiviru
carri
shrna
lung
rat
underw
midlin
incis
expos
trachea
isofluran
anesthesia
briefli
anesthet
rat
place
supin
posit
inclin
platform
approxim
trachea
expos
surgic
ventral
side
neck
needl
insert
tracheal
wall
lumen
blow
larynx
empti
viru
control
viral
particl
l
l
phosphatebuff
salin
directli
inject
trachea
follow
l
air
enhanc
spread
viru
rat
lung
inject
perform
day
later
one
week
last
lentivir
treatment
anim
subject
lp
administr
lpsinduc
acut
lung
injuri
acut
lung
injuri
ali
induc
singl
intraven
inject
lp
mgkg
previous
describ
control
rat
receiv
nacl
solut
l
tail
vein
treatment
group
gkg
mgkg
inject
via
rat
tail
vein
min
induct
ali
anim
breath
spontan
experiment
protocol
eight
hour
lp
administr
anim
anesthet
intraperiton
inject
pentobarbit
sodium
mgkg
euthan
exsanguin
serum
sampl
collect
store
bronchoalveolar
lavag
fluid
balf
collect
three
lavag
sampl
left
lung
aliquot
ml
normal
salin
greater
recoveri
salin
achiev
retriev
balf
pool
centrifug
g
min
supernat
store
aliquot
right
lung
fix
immedi
paraformaldehyd
investig
role
mapk
pathway
develop
ard
effect
overexpress
mapk
specif
inhibitor
mgkg
pretreat
intraperiton
time
min
lp
administr
histopatholog
embed
lung
tissu
cut
mthick
section
stain
hematoxylineosin
microscop
observ
degre
lung
injuri
semiquantit
score
describ
murakami
colleagu
briefli
lung
injuri
score
includ
edema
inflamm
hemorrhag
grade
follow
scale
normal
light
moder
strong
sever
analysi
conduct
pathologist
blind
experiment
group
valu
three
paramet
analyz
ad
final
lung
injuri
score
averag
score
calcul
within
experiment
group
assess
lung
permeabl
rat
protein
concentr
bal
fluid
measur
briefli
balf
sampl
l
left
lung
centrifug
g
min
protein
concentr
supernat
quantifi
bca
protein
assay
pierc
il
usa
balf
level
angii
ang
measur
use
elisa
assay
accord
manufactur
instruct
western
blot
analysi
total
protein
extract
frozen
lung
tissu
use
tper
tissu
protein
extract
reagent
pierc
il
usa
equal
amount
protein
g
run
sdspage
gel
transfer
onto
polyvinyliden
difluorid
membran
millipor
membran
block
skim
milk
tbst
room
temperatur
h
incub
primari
antibodi
rat
phosphoryl
jnk
phosphoryl
jnk
mapk
phosphoryl
mapk
phosphoryl
actin
overnight
wash
tbst
blot
incub
secondari
hrpconjug
antimouserabbit
igg
room
temperatur
h
wash
tbst
membran
develop
ecl
detect
kit
pierc
il
usa
imag
xray
film
realtim
pcr
total
rna
extract
lung
tissu
trizol
reagent
invitrogen
usa
quantit
realtim
pcr
perform
use
thermal
cycler
dice
real
time
system
takara
japan
briefli
solut
g
rna
mix
l
oligo
dt
primer
dilut
final
volum
l
rnase
free
distil
water
dh
incub
min
kept
ice
min
solut
mix
l
buffer
l
mm
dntp
mixtur
takara
l
l
ribonucleas
inhibitor
takara
l
l
rnase
mmlv
dilut
l
rnase
dh
incub
min
min
next
reaction
mixtur
contain
l
cdna
l
primer
f
l
primer
r
l
sybr
premix
ex
taq
takara
dilut
l
rnase
dh
kept
min
reaction
condit
follow
cycl
sec
sec
sec
method
use
analyz
rel
mrna
level
target
gene
fold
chang
normal
betaactin
gene
rel
sham
group
follow
primer
use
forward
primer
revers
primer
ma
forward
primer
revers
primer
forward
primer
cctaaggccaa
revers
primer
statist
analys
statist
analys
perform
prism
softwar
packag
graphpad
san
diego
ca
usa
valu
present
mean
standard
deviat
sd
data
analyz
use
scientif
report
doi
oneway
anova
newmankeul
test
multipl
comparison
pvalu
less
consid
statist
signific
lentiviralmedi
gene
transfer
effici
increas
downregul
mrna
protein
express
rat
lung
tissu
compar
control
anim
mrna
protein
level
lung
tissu
group
rat
lung
transfect
increas
fold
respect
contrast
mrna
protein
level
infect
rat
lung
group
decreas
signific
differ
mrna
protein
express
control
group
lvnc
group
rat
lung
transfect
recombin
lentiviru
carri
neg
control
shrna
result
show
high
effici
gene
transfer
rat
lung
via
intratrach
inject
fig
c
prevent
rat
lpsinduc
acut
lung
injuri
hour
lp
treatment
result
acut
lung
injuri
demonstr
edema
inflamm
hemorrhag
fig
lung
injuri
score
fig
balf
protein
level
fig
lp
group
significantli
increas
compar
control
group
overexpress
rat
lung
markedli
attenu
lpsinduc
lung
injuri
decreas
lung
injuri
score
balf
protein
level
sharp
contrast
silenc
notic
deterior
lpsinduc
lung
injuri
evidenc
increas
lung
injuri
score
balf
protein
level
furthermor
pretreat
either
potent
select
antagonist
ang
via
competit
bind
specif
ma
receptor
inhibitor
significantli
inhibit
protect
effect
lpsinduc
lung
injuri
lung
injuri
score
balf
protein
level
lp
group
significantli
higher
lp
group
suggest
protect
rat
lpsinduc
acut
lung
injuri
partial
via
masmedi
signal
lp
administr
level
ang
ii
fig
ang
fig
balf
significantli
increas
compar
control
group
overexpress
significantli
reduc
balf
ang
ii
concentr
enhanc
ang
level
ratio
ang
ii
ang
markedli
drop
lp
group
lp
group
pretreat
transduc
rat
revers
decreas
ang
ii
level
increas
ang
level
balf
ratio
ang
ii
ang
notabl
increas
lp
group
lp
group
respect
addit
rnai
also
significantli
increas
ang
ii
level
decreas
ang
level
ratio
ang
ii
ang
increas
highest
level
group
fig
fig
fig
concentr
balf
rat
expos
lp
significantli
higher
control
group
lpsinduc
secret
balf
dramat
inhibit
overexpress
promot
knockdown
rat
balf
treatment
prior
lp
inject
result
obviou
increas
balf
rat
transduc
concentr
balf
lp
group
lp
group
similar
lp
group
result
demonstr
lp
mainli
promot
gener
ang
ii
enhanc
cytokin
secret
abolish
overexpress
overexpress
rat
lung
significantli
enhanc
lpsinduc
secret
balf
abolish
pretreat
interestingli
knockdown
rat
lung
also
promot
level
balf
lp
administr
result
suggest
antiinflammatori
respons
may
also
trigger
lung
lp
exposur
counter
effect
proinflammatori
cytokin
promot
antiinflammatori
respons
via
ang
ma
pathway
overexpress
revers
lpsinduc
decreas
enhanc
ma
mrna
increas
lung
lp
administr
result
signific
decreas
protein
rat
lung
upregul
transduct
attenu
fig
upregul
protein
express
rat
lung
suppress
pretreat
lp
inject
express
lp
group
similar
lp
group
upregul
overexpress
reduc
knockdown
pretreat
revers
chang
ang
ii
ang
result
overexpress
cf
level
significantli
increas
hour
lp
inject
overexpress
markedli
suppress
secret
increas
level
notic
abolish
pretreat
increas
level
caus
lp
administr
promot
knockdown
data
repres
mean
sd
p
versu
control
group
p
versu
lp
group
p
versu
group
n
per
group
ma
mrna
upregul
lung
tissu
rat
expos
lp
overexpress
caus
signific
increas
ma
mrna
lp
stimul
rat
lung
knockdown
markedli
suppress
ma
mrna
express
treatment
lp
administr
significantli
reduc
express
ma
mrna
transduc
rat
lung
signific
differ
ma
mrna
express
lp
group
control
group
fig
blot
result
show
lp
administr
induc
phosphoryl
mapk
fig
fig
jnk
fig
overexpress
significantli
suppress
phosphoryl
level
mapk
jnk
lung
tissu
rat
receiv
lp
inhibitori
effect
overexpress
lpsinduc
mapk
phosphoryl
complet
abolish
pretreat
meanwhil
signific
differ
jnk
phosphoryl
lp
significantli
suppress
overexpress
rat
lung
pretreat
complet
abolish
inhibitori
effect
overexpress
lpsinduc
mapk
phosphoryl
affect
level
jnk
phosphoryl
rnai
rat
lung
significantli
enhanc
lpsinduc
jnk
phosphoryl
chang
mapk
phosphoryl
data
repres
mean
sd
p
versu
control
group
p
versu
lp
group
p
versu
group
n
per
group
scientif
report
doi
lp
compar
lp
group
addit
knock
rat
lung
significantli
enhanc
lpsinduc
increas
jnk
phosphoryl
rat
lung
signific
differ
mapk
phosphoryl
level
lp
group
lp
group
fig
infect
rat
attenu
lpsinduc
lung
injuri
evidenc
reduc
lung
injuri
score
balf
protein
level
fig
b
e
balf
protein
level
rat
lp
group
lp
group
significantli
reduc
pretreat
lpsinduc
lung
injuri
also
attenu
mpak
inhibitor
prior
lp
administr
rat
two
group
fig
f
g
howev
evalu
lung
injuri
score
show
statist
differ
rat
without
mpak
inhibitor
pretreat
lp
group
lp
group
except
rat
lp
group
pretreat
show
signific
decreas
lung
injuri
score
fig
addit
balf
cytokin
dramat
reduc
specif
mapk
inhibitor
pretreat
rat
lp
lp
lp
group
fig
result
indic
block
mapk
pathway
remark
attenu
lpsinduc
inflammatori
respons
infect
rat
pretreat
rat
overexpress
furthermor
histolog
evalu
whole
lung
injuri
demonstr
pretreat
specif
mapk
inhibitor
significantli
attenu
lpsinduc
lung
injuri
infect
rat
significantli
revers
blockad
effect
overexpress
prevent
lpsinduc
lung
injuri
special
inhibit
pathway
significantli
attenu
lpsinduc
cytokin
secret
lung
injuri
overexpress
rat
pretreat
ma
receptor
antagonist
administr
b
phosphoryl
level
significantli
increas
express
clearli
decreas
lung
compar
control
rat
overexpress
rat
lung
markedli
suppress
lpsinduc
b
phosphoryl
enhanc
express
complet
abolish
pretreat
furthermor
b
phosphoryl
level
higher
lp
group
lp
group
lp
group
compar
lp
group
downregul
enhanc
lpsinduc
increas
b
phosphoryl
level
lung
tissu
differ
b
phosphoryl
level
lp
group
lp
group
meanwhil
express
level
lp
group
significantli
lower
control
group
still
higher
compar
lp
group
fig
studi
demonstr
lp
administr
evok
sever
lung
injuri
character
increas
inflammatori
cell
infiltr
edema
hemorrhag
interstitium
alveolu
well
increas
level
balf
result
also
show
lp
administr
significantli
reduc
express
rat
lung
wherea
overexpress
significantli
attenu
lpsinduc
lung
injuri
suppress
inflammatori
respons
abolish
inhibitor
knockdown
caus
mark
deterior
lung
injuri
increas
cytokin
secret
rat
receiv
lp
inject
togeth
find
suggest
local
lung
tissu
prevent
lpsinduc
lung
injuri
inflamm
may
use
therapeut
agent
target
ard
activ
reninangiotensin
system
play
central
role
pathophysiolog
ard
suppress
aceang
axi
shown
improv
symptom
ard
differ
ard
model
loss
mice
result
aggrav
lung
injuri
wherea
recombin
attenu
symptom
ard
mice
especi
wild
type
mice
lung
injuri
ard
mous
model
caus
limb
ischemiareperfus
lir
deterior
deplet
protect
transgen
chang
express
lung
tissu
accompani
alter
ang
iiang
ratio
prior
studi
shown
downregul
express
lung
increas
serum
ang
ii
level
associ
sever
respiratori
syncyti
viru
ard
also
amelior
administr
recombin
human
moreov
decreas
activ
balf
ventil
anim
expos
lp
correl
enhanc
balf
ang
ii
reduc
ang
level
similar
previou
studi
result
show
overexpress
rat
lung
reduc
balf
ang
ii
level
increas
ang
level
anim
treat
lp
ratio
ang
ii
ang
balf
significantli
decreas
overexpress
markedli
increas
knockdown
despit
evid
suggest
decreas
ang
level
lung
tissu
develop
ard
conflict
result
publish
literatur
ang
level
balf
increas
mechan
ventilationinduc
rat
lung
injuri
decreas
hour
lp
administr
mous
ard
model
ang
lung
tissu
shown
decreas
hour
lp
challeng
earli
stage
lirinduc
ard
lung
tissu
ang
level
significantli
increas
hour
persist
hour
reperfus
present
studi
found
lp
administr
caus
signific
increas
ang
ii
also
unexpect
increas
ang
balf
reninangiotensin
system
ang
mainli
gener
hydrolyz
ang
ii
also
gener
ace
catalyz
ang
possibl
increas
level
ang
lung
tissu
may
play
compensatori
role
initi
develop
ard
discoveri
ang
major
product
stimul
downstream
ma
receptor
oppos
effect
ang
suggest
ang
may
contribut
protect
effect
ma
agonist
prevent
ventilatoror
acid
aspirationinduc
lung
injuri
revers
ma
receptor
antagonist
present
studi
demonstr
ma
receptor
antagonist
effect
abolish
protect
effect
overexpress
lung
rat
expos
lp
addit
ma
receptor
antagonist
also
revers
decreas
ang
ii
increas
ang
balf
transduc
rat
elev
ang
iiang
ratio
result
indic
protect
effect
lpsinduc
lung
injuri
primarili
depend
ang
ma
pathway
recent
studi
found
infus
ang
enhanc
ma
mrna
express
bleomycininduc
lung
injuri
model
furthermor
overexpress
rostral
ventrolater
medulla
spontan
hypertens
rat
increas
express
ma
studi
found
overexpress
result
signific
increas
ma
mrna
express
lpsstimul
rat
lung
knockdown
remark
suppress
ma
mrna
express
moreov
blockad
ma
receptor
reduc
express
lung
tissu
also
significantli
suppress
ma
mrna
express
data
suggest
protect
effect
lung
injuri
depend
ma
signal
cascad
also
upregul
ma
receptor
express
underli
molecular
mechan
protect
ard
remain
elus
previou
studi
indic
activ
mapk
signal
promot
progress
ard
function
linkag
mapk
pathway
ma
signal
axi
lpsinduc
lung
injuri
elucid
current
studi
show
lp
administr
stimul
phosphoryl
mapk
jnk
significantli
reduc
overexpress
lung
tissu
moreov
shrna
enhanc
phosphoryl
jnk
rat
lung
either
ma
receptor
antagonist
inhibitor
complet
abolish
inhibitori
effect
lpsinduc
mapk
phosphoryl
combin
prevent
ang
iimedi
myocardi
injuri
block
activ
addit
shown
regul
balanc
angiiang
prevent
alveolar
epitheli
cell
apoptosi
jnk
phosphoryl
pretreat
abolish
antiapoptot
effect
ang
inhibit
jnk
phosphoryl
overexpress
pmvec
protect
lpsinduc
apoptosi
suppress
mapkjnk
phosphoryl
attenu
pretreat
data
indic
suppress
mapk
activ
ma
signal
pathway
cell
type
depend
investig
whether
mapk
pathway
play
role
protect
effect
lpsinduc
lung
injuri
specif
mapk
inhibitor
pretreat
intraperiton
rat
receiv
lp
inject
pretreat
jnk
inhibitor
significantli
attenu
lpsinduc
inflammatori
respons
injuri
rat
lung
knockdown
moreov
ma
receptor
antagonist
inhibitor
abolish
protect
effect
overexpress
lpsinduc
protein
cytokin
secret
balf
obvious
revers
specif
mapk
inhibitor
wherea
inhibitor
significantli
attenu
lung
injuri
overexpress
rat
pretreat
result
suggest
may
signal
pathway
involv
mechan
protect
effect
lpsinduc
lung
injuri
b
famili
includ
rela
relb
crel
exist
homoor
heterodim
cytoplasm
maintain
inact
state
bind
b
protein
upon
stimul
lp
proinflammatori
cytokin
b
protein
phosphoryl
activ
b
kinas
ikk
degrad
lead
activ
transloc
b
nucleu
upregul
transcript
inflammatori
gene
activ
b
pivot
develop
endotoxininduc
ard
anim
imai
et
al
identifi
b
signal
pathway
key
role
control
sever
acut
lung
injuri
present
vivo
studi
overexpress
rat
lung
significantli
suppress
lpsinduc
b
phosphoryl
enhanc
express
complet
revers
ma
receptor
antagonist
inhibitor
pretreat
contrast
overexpress
silenc
markedli
enhanc
lpsinduc
activ
b
degrad
result
indic
b
signal
pathway
also
import
may
cooper
mapk
pathway
facilit
protect
effect
lpsinduc
ard
result
vitro
studi
also
suggest
prevent
pmvec
lpsinduc
apoptosi
inflamm
inhibit
jnk
b
activ
find
consist
figur
effect
differ
treatment
lpsinduc
activ
pathway
lp
exposur
caus
mark
increas
phosphoryl
b
decreas
express
significantli
revers
overexpress
rat
lung
pretreat
complet
abolish
inhibitori
effect
overexpress
lpsinduc
b
phosphoryl
reduc
express
rnai
rat
lung
significantli
enhanc
lpsinduc
b
phosphoryl
chang
b
phosphoryl
data
repres
mean
sd
p
versu
control
group
p
versu
lp
group
p
versu
group
n
per
group
previou
observ
pharmacolog
inhibit
erk
attenu
lpsinduc
lung
injuri
via
suppress
activ
nfkb
pathway
summari
previou
studi
data
present
suggest
protect
lung
injuri
like
via
gener
ang
turn
stimul
masmedi
signal
inhibit
b
activ
process
ard
fig
clinic
intraven
administr
recombin
human
healthi
human
result
increas
decreas
unchang
ang
serum
concentr
without
cardiovascular
effect
clinic
trial
perform
petti
wj
et
al
ang
administr
led
decreas
plasma
placent
growth
factor
level
cancer
patient
clinic
benefit
suggest
ang
ma
pathway
promis
therapeut
target
ard
